High-throughput tandem-microwell assay for ammonia repositions FDA-Approved drugs to Helicobacter pylori infection
F. Liu, J. Yu, Y. Zhang, F. Li, Q. Liu, Y. Zhou, S. Huang, H. Fang, Z. Xiao, L. Liao, J. Xu, X.-Y. Wu, F. Wu
This study identifies FDA-approved drugs that inhibit urease activity in H. pylori, offering potential new treatments for infections.
bioRxiv · Jan 5, 2021 · PreprintBiochemistry